Literature DB >> 3449312

Gold-induced aplastic anemia.

L M Williame1, R Joos, F Proot, C Immesoete.   

Abstract

Three patients receiving gold salt treatment for rheumatoid arthritis developed severe aplastic anemia. All three patients experienced remission of their disease at the time of the occurrence of marrow aplasia. Reviewing data on these patients and recent literature indicate that fatal marrow aplasia seems to occur more frequently in sero-negative women who respond well to therapy with gold salts. Frequent blood monitoring in search for any pronounced or sustained drop in red, white or platelet count, even within normal range could serve as a warning sign for myelotoxicity. Despite intensive supportive measures and specific therapeutic attempts, all three patients eventually died of septic shock.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3449312     DOI: 10.1007/BF02330601

Source DB:  PubMed          Journal:  Clin Rheumatol        ISSN: 0770-3198            Impact factor:   2.980


  20 in total

1.  A fatality due to the use of gold.

Authors:  R B PROWSE
Journal:  Br Med J       Date:  1954-10-16

2.  Immunological studies on the mechanism of gold hypersensitivity reactions.

Authors:  P Davis; A Ezeoke; J Munro; J R Hobbs; G R Hughes
Journal:  Br Med J       Date:  1973-09-29

3.  Monitoring serum gold values to improve chrysotherapy in rheumatoid arthritis.

Authors:  A Lorber; C J Atkins; C C Chang; Y B Lee; J Starrs; R A Bovy
Journal:  Ann Rheum Dis       Date:  1973-03       Impact factor: 19.103

4.  Gold in rheumatoid arthritis.

Authors:  J D Jessop
Journal:  Br Med J       Date:  1971-01-02

5.  The lymphocyte transformation test and gold hypersensitivity.

Authors:  E J Denman; A M Denman
Journal:  Ann Rheum Dis       Date:  1968-11       Impact factor: 19.103

6.  Myelotoxicity of gold.

Authors:  A G Kay
Journal:  Br Med J       Date:  1976-05-22

7.  Deaths associated with gold treatment: a reassessment.

Authors:  J M Gumpel
Journal:  Br Med J       Date:  1978-01-28

8.  Chrysotherapy. Suppression of immunoglobulin synthesis.

Authors:  A Lorber; T Simon; J Leeb; A Peter; S Wilcox
Journal:  Arthritis Rheum       Date:  1978 Sep-Oct

9.  Bone marrow transplantation in patients with gold-induced marrow aplasia.

Authors:  J L Baldwin; R Storb; E D Thomas; M Mannik
Journal:  Arthritis Rheum       Date:  1977-06

Review 10.  Aplastic anemia in association with gold therapy for rheumatoid arthritis.

Authors:  J Gibson; E E McGirr; J York; H Kronenberg
Journal:  Aust N Z J Med       Date:  1983-04
View more
  3 in total

Review 1.  Drug-induced myelosuppression : diagnosis and management.

Authors:  Peter J Carey
Journal:  Drug Saf       Date:  2003       Impact factor: 5.606

2.  Disease-modifying drugs for rheumatoid arthritis. Asset or liability?

Authors:  H A Bird
Journal:  Clin Rheumatol       Date:  1987-12       Impact factor: 2.980

3.  Auranofin mitigates systemic iron overload and induces ferroptosis via distinct mechanisms.

Authors:  Lei Yang; Hao Wang; Xiang Yang; Qian Wu; Peng An; Xi Jin; Weiwei Liu; Xin Huang; Yuzhu Li; Shiyu Yan; Shuying Shen; Tingbo Liang; Junxia Min; Fudi Wang
Journal:  Signal Transduct Target Ther       Date:  2020-07-31
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.